NCT02180763 - Gammanorm Quality of Life Study in Immunodeficient Patients Using Rapid Push or Pumps | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

August 28, 2016

Study Completion Date

August 26, 2017

Conditions

Primary Immunodeficiency (PID)

Interventions

BIOLOGICAL

Gammanorm

Sub-Q IgG

Trial Locations (8)

Haut-Leveque Hospital, Bordeaux

University Hospital of Caen, Caen

University Hospital of Lille, Lille

Hospital Dupuytren, Limoges

Clinique Mutualiste, Lyon

University Hospital of Reims, Reims

University Hospital of Toulouse, Toulouse

University Hospital of Tours, Tours